Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases

LS Munoz-Price, L Poirel, RA Bonomo… - The Lancet infectious …, 2013 - thelancet.com
Klebsiella pneumoniae carbapenemases (KPCs) were originally identified in the USA in
1996. Since then, these versatile β-lactamases have spread internationally among Gram …

Deaths attributable to carbapenem-resistant Enterobacteriaceae infections

ME Falagas, GS Tansarli… - Emerging infectious …, 2014 - pmc.ncbi.nlm.nih.gov
We evaluated the number of deaths attributable to carbapenem-resistant
Enterobacteriaceae by using studies from around the world published before April 9, 2012 …

[HTML][HTML] Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe

R Cantón, M Akóva, Y Carmeli, CG Giske… - Clinical microbiology …, 2012 - Elsevier
Plasmid-acquired carbapenemases in Enterobacteriaceae, which were first discovered in
Europe in the 1990s, are now increasingly being identified at an alarming rate. Although …

A systematic review and meta-analyses of the clinical epidemiology of carbapenem-resistant Enterobacteriaceae

K van Loon, AF Voor in 't holt… - Antimicrobial agents and …, 2018 - journals.asm.org
Carbapenem-resistant Enterobacteriaceae (CRE) are major health care-associated
pathogens and responsible for hospital outbreaks worldwide. To prevent a further increase …

A review on bacterial resistance to carbapenems: epidemiology, detection and treatment options

AA Elshamy, KM Aboshanab - Future science OA, 2020 - Taylor & Francis
Carbapenems are a class of antimicrobial agents reserved for infections caused by
multidrug-resistant microorganisms. The emergence of carbapenem resistance has become …

Carbapenemase-producing enterobacteriaceae

Y Doi, DL Paterson - Seminars in respiratory and critical care …, 2015 - thieme-connect.com
Carbapenemase-producing Enterobacteriaceae (CPE) were almost nonexistent up to the
1990s, but are today encountered routinely in hospitals and other healthcare facilities in …

Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009 …

HS Sader, DJ Farrell, RK Flamm, RN Jones - Diagnostic microbiology and …, 2014 - Elsevier
Abstract Treatment of infections in the intensive care unit (ICU) represents a great challenge,
especially those caused by Gram-negative organisms. Rapid introduction of appropriate …

Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013

C Glasner, B Albiger, G Buist, AT Andrasević… - …, 2013 - research.rug.nl
The spread of carbapenemase-producing Enterobacteriaceae (CPE) is a threat to
healthcare delivery, although its extent differs substantially from country to country. In …

Epidemic diffusion of KPC carbapenemase-producing Klebsiella pneumoniae in Italy: results of the first countrywide survey, 15 May to 30 June 2011

T Giani, B Pini, F Arena, V Conte, S Bracco… - …, 2013 - flore.unifi.it
Carbapenem-resistant Enterobacteriaceae (CRE) are emerging as a public health problem
in various settings. In Italy, a rapid and remarkable increase of carbapenem-non-susceptible …

Mortality due to KPC carbapenemase-producing Klebsiella pneumoniae infections: systematic review and meta-analysis: mortality due to KPC Klebsiella pneumoniae …

JA Ramos-Castañeda, A Ruano-Ravina… - Journal of Infection, 2018 - Elsevier
Introduction KPC carbapenemase-producing Klebsiella pneumoniae (KPC-KP) has become
a major public health challenge. Accordingly, this study sought to use a systematic review of …